Direct assessment of drug penetration into tissue using a novel application of three-dimensional cell culture

Alastair H Kyle1, Lynsey A Huxham, Aaron S J Chiam

  • 1Department of Medical Biophysics, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.

Cancer Research
|September 3, 2004
PubMed

Insights

Many anticancer drugs fail in solid tumors due to poor tissue penetration. A new assay reveals significant drug loss, highlighting the need for better anticancer drug delivery strategies.

Area of Science:

  • Oncology
  • Pharmacology
  • Biomedical Engineering

Background:

  • Solid tumor growth is often limited by insufficient drug delivery to distant regions.
  • Developing new anticancer drugs lacks methods to assess tumor tissue penetration.
  • Effective drug penetration is crucial for solid cancer treatment efficacy.

Purpose of the Study:

  • To develop and validate a novel multilayered cell culture assay for assessing anticancer drug penetration.
  • To evaluate the tissue distribution and penetration of anthracycline analogues using the developed assay.
  • To identify anticancer drugs with improved tumor penetration properties.

Main Methods:

  • A novel multilayered cell culture assay was designed to mimic tumor tissue.
  • Drug penetration was assessed by exposing one side of a 150-microm thick tissue disk and measuring cell effects on the opposite side.
  • Bromodeoxyuridine (BrdU) detection of S-phase cells was used to quantify drug penetration and efficacy.

Main Results:

  • None of the tested anthracycline analogues effectively penetrated the tissue to affect distant cells at clinically relevant exposures.
  • Doxorubicin and epirubicin showed approximately 10-fold decreases in efficacy on the far side, while daunorubicin and mitoxantrone showed 30-fold and >30-fold decreases, respectively.
  • Drug-derived fluorescence gradients confirmed the observed penetration patterns.

Conclusions:

  • The developed multilayered cell culture assay effectively quantifies anticancer drug penetration.
  • Current anthracycline analogues exhibit limited penetration in simulated tumor tissue.
  • This assay can serve as a screening tool for discovering anticancer drugs with enhanced tissue penetration capabilities.